Literature DB >> 20855643

The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers.

Torahiko Jinta1, Yasunari Miyazaki, Masato Kishi, Takumi Akashi, Tamiko Takemura, Naohiko Inase, Yasuyuki Yoshizawa.   

Abstract

Previous studies showed that apoptotic epithelial cells were involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP); however, little is known about apoptosis in chronic hypersensitivity pneumonitis (HP). This study was performed to examine whether apoptosis has a role in chronic HP. We performed immunohistochemical studies for p53, p21, Fas, Fas ligand, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick-end labeling methods on surgical lung specimens. The expression of Fas and Fas ligand was up-regulated in UIP-like lesions compared with nonspecific interstitial pneumonia (NSIP)-like lesions. The expression of p53 and p21 on epithelial cells increased significantly in UIP-like lesions compared with fibrotic NSIP-like lesions and in fibrotic NSIP-like lesions compared with normal lung tissues. These results confirm that apoptotic epithelial cells are present in chronic HP as seen in IPF. Augmented epithelial apoptosis may contribute much more to UIP-like lesions than to NSIP-like lesions in chronic HP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855643     DOI: 10.1309/AJCPK8RPQX7TQRQC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

Review 1.  Myofibroblast differentiation and survival in fibrotic disease.

Authors:  Kornelia Kis; Xiaoqiu Liu; James S Hagood
Journal:  Expert Rev Mol Med       Date:  2011-08-23       Impact factor: 5.600

2.  Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.

Authors:  Baek Gil Kim; Ming-Qing Gao; Yoon Pyo Choi; Suki Kang; Haeng Ran Park; Kyu Sub Kang; Nam Hoon Cho
Journal:  Breast Cancer Res       Date:  2012-06-06       Impact factor: 6.466

Review 3.  Innate immunity and the pathogenicity of inhaled microbial particles.

Authors:  C Henrik J Wolff
Journal:  Int J Biol Sci       Date:  2011-03-15       Impact factor: 6.580

4.  Apoptosis and the airway epithelium.

Authors:  Steven R White
Journal:  J Allergy (Cairo)       Date:  2011-12-13

5.  Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.

Authors:  Jürgen Behr; Petra Neuser; Antje Prasse; Michael Kreuter; Klaus Rabe; Carmen Schade-Brittinger; Jasmin Wagner; Andreas Günther
Journal:  BMC Pulm Med       Date:  2017-09-06       Impact factor: 3.317

6.  Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study.

Authors:  Vasilios Tzilas; Argyris Tzouvelekis; Evangelos Bouros; Theodoros Karampitsakos; Maria Ntassiou; Eleni Avdoula; Athena Trachalaki; Katerina Antoniou; Ganesh Raghu; Demosthenes Bouros
Journal:  ERJ Open Res       Date:  2020-11-02

7.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

Review 8.  VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.

Authors:  Shaney L Barratt; Victoria A Flower; John D Pauling; Ann B Millar
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

9.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

Review 10.  Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update.

Authors:  Helmut H Popper
Journal:  Virchows Arch       Date:  2012-12-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.